JPH04218385A - Production of r(-)-mandelic acid - Google Patents
Production of r(-)-mandelic acidInfo
- Publication number
- JPH04218385A JPH04218385A JP8918991A JP8918991A JPH04218385A JP H04218385 A JPH04218385 A JP H04218385A JP 8918991 A JP8918991 A JP 8918991A JP 8918991 A JP8918991 A JP 8918991A JP H04218385 A JPH04218385 A JP H04218385A
- Authority
- JP
- Japan
- Prior art keywords
- mandelonitrile
- mandelic acid
- acid
- reaction
- benzaldehyde
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 title claims abstract description 35
- 238000004519 manufacturing process Methods 0.000 title claims description 13
- IWYDHOAUDWTVEP-SSDOTTSWSA-N (R)-mandelic acid Chemical compound OC(=O)[C@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-SSDOTTSWSA-N 0.000 title abstract description 23
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims abstract description 30
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 claims abstract description 30
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims abstract description 15
- 241000588986 Alcaligenes Species 0.000 claims abstract description 6
- 241000589516 Pseudomonas Species 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 4
- 125000002560 nitrile group Chemical group 0.000 claims abstract description 3
- 244000005700 microbiome Species 0.000 claims description 13
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 claims description 10
- 229960002510 mandelic acid Drugs 0.000 claims description 10
- 241000589291 Acinetobacter Species 0.000 claims description 7
- 241000186216 Corynebacterium Species 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 239000012736 aqueous medium Substances 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims 1
- NNICRUQPODTGRU-UHFFFAOYSA-N mandelonitrile Chemical compound N#CC(O)C1=CC=CC=C1 NNICRUQPODTGRU-UHFFFAOYSA-N 0.000 abstract description 44
- 241000894006 Bacteria Species 0.000 abstract description 10
- 241000589774 Pseudomonas sp. Species 0.000 abstract description 4
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 2
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 28
- 239000000243 solution Substances 0.000 description 14
- 230000001580 bacterial effect Effects 0.000 description 12
- 238000006460 hydrolysis reaction Methods 0.000 description 11
- 230000007062 hydrolysis Effects 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- MAGPZHKLEZXLNU-UHFFFAOYSA-N mandelamide Chemical compound NC(=O)C(O)C1=CC=CC=C1 MAGPZHKLEZXLNU-UHFFFAOYSA-N 0.000 description 6
- 241000588810 Alcaligenes sp. Species 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 239000012069 chiral reagent Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- -1 malt extract Substances 0.000 description 3
- 229940099596 manganese sulfate Drugs 0.000 description 3
- 239000011702 manganese sulphate Substances 0.000 description 3
- 235000007079 manganese sulphate Nutrition 0.000 description 3
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- SUSQOBVLVYHIEX-UHFFFAOYSA-N phenylacetonitrile Chemical compound N#CCC1=CC=CC=C1 SUSQOBVLVYHIEX-UHFFFAOYSA-N 0.000 description 3
- 230000036647 reaction Effects 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 3
- 229960001763 zinc sulfate Drugs 0.000 description 3
- 229910000368 zinc sulfate Inorganic materials 0.000 description 3
- VTESCYNPUGSWKG-UHFFFAOYSA-N (4-tert-butylphenyl)hydrazine;hydrochloride Chemical compound [Cl-].CC(C)(C)C1=CC=C(N[NH3+])C=C1 VTESCYNPUGSWKG-UHFFFAOYSA-N 0.000 description 2
- LSBDFXRDZJMBSC-UHFFFAOYSA-N 2-phenylacetamide Chemical compound NC(=O)CC1=CC=CC=C1 LSBDFXRDZJMBSC-UHFFFAOYSA-N 0.000 description 2
- ACRWYXSKEHUQDB-UHFFFAOYSA-N 3-phenylpropionitrile Chemical compound N#CCCC1=CC=CC=C1 ACRWYXSKEHUQDB-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 238000011914 asymmetric synthesis Methods 0.000 description 2
- 238000010170 biological method Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- 235000019800 disodium phosphate Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IWYDHOAUDWTVEP-ZETCQYMHSA-N (S)-mandelic acid Chemical compound OC(=O)[C@@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-ZETCQYMHSA-N 0.000 description 1
- NNICRUQPODTGRU-MRVPVSSYSA-N (S)-mandelonitrile Chemical compound N#C[C@@H](O)C1=CC=CC=C1 NNICRUQPODTGRU-MRVPVSSYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZFCFFNGBCVAUDE-UHFFFAOYSA-N 2-(benzenesulfonyl)acetonitrile Chemical compound N#CCS(=O)(=O)C1=CC=CC=C1 ZFCFFNGBCVAUDE-UHFFFAOYSA-N 0.000 description 1
- FFNVQNRYTPFDDP-UHFFFAOYSA-N 2-cyanopyridine Chemical compound N#CC1=CC=CC=N1 FFNVQNRYTPFDDP-UHFFFAOYSA-N 0.000 description 1
- WXVKGHVDWWXBJX-UHFFFAOYSA-N 3-morpholin-4-ylpropanenitrile Chemical compound N#CCCN1CCOCC1 WXVKGHVDWWXBJX-UHFFFAOYSA-N 0.000 description 1
- GZPHSAQLYPIAIN-UHFFFAOYSA-N 3-pyridinecarbonitrile Chemical compound N#CC1=CC=CN=C1 GZPHSAQLYPIAIN-UHFFFAOYSA-N 0.000 description 1
- 241000588625 Acinetobacter sp. Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 1
- 241000190932 Rhodopseudomonas Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000001782 cephems Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229940047889 isobutyramide Drugs 0.000 description 1
- LRDFRRGEGBBSRN-UHFFFAOYSA-N isobutyronitrile Chemical compound CC(C)C#N LRDFRRGEGBBSRN-UHFFFAOYSA-N 0.000 description 1
- VFQXVTODMYMSMJ-UHFFFAOYSA-N isonicotinamide Chemical compound NC(=O)C1=CC=NC=C1 VFQXVTODMYMSMJ-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- GPHQHTOMRSGBNZ-UHFFFAOYSA-N pyridine-4-carbonitrile Chemical compound N#CC1=CC=NC=C1 GPHQHTOMRSGBNZ-UHFFFAOYSA-N 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明はR(−)−マンデル酸の
製造法に関する。更に詳しくは、マンデロニトリルに対
して不斉加水分解能を有する微生物を用いて、R(−)
−マンデル酸を製造する方法に関する。R(−)−マン
デル酸は、セフェム系抗生物質の合成原料として、また
、多種の医農薬品の合成原料として工業的に重要である
。FIELD OF THE INVENTION The present invention relates to a method for producing R(-)-mandelic acid. More specifically, using a microorganism that has the ability to asymmetrically hydrolyze mandelonitrile, R(-)
- A method for producing mandelic acid. R(-)-mandelic acid is industrially important as a raw material for the synthesis of cephem antibiotics and as a raw material for the synthesis of various pharmaceutical and agricultural products.
【0002】0002
【従来の技術とその問題点】R(−)−マンデル酸の製
造法として公知のものに化学的に合成したR,S−マン
デル酸(ラセミ体)を、(1) 分別結晶によるラセミ
分割〔特開昭58−177933 号公報参照〕、(2
) クロマトグラフィーによるラセミ分割〔EP 98
707号公報参照〕、(3) ラセミ体エステルと成し
酵素的不斉加水分解によるラセミ分割〔K. Mori
et al.,Tetrahedron 36,
91 (1980) 参照〕するなどのラセミ分割法、
(4) キラル試薬を用いた化学的不斉合成法〔D.
A. Evans et al., J. Am. C
hem. Soc. 107, 4346 (198
5) 参照〕などが有る。また、生物学的方法としては
、上記のエステル不斉加水分解法のほかに、(5) ベ
ンゾイルギ酸の微生物的不斉還元〔特開昭57−198
096 号公報参照〕、(6) D−オキシニトリラー
ゼにより不斉合成したR(−)−マンデロニトリルの加
水分解〔特開昭63−219388 号公報参照〕、(
7) アルカリゲネス属、シュウドモナス属、ロドシュ
ウドモナス属、コリネバクテリウム属、アシネトバクタ
ー属、バチルス属、マイコバクテリウム属、ロドコッカ
ス属またはキャンディダ属の微生物によるラセミ体のマ
ンデロニトリルまたはマンデルアミドの不斉加水分解に
よるR(−)−マンデル酸の製造法〔特開平2−841
98 号公報参照〕などが知られている。[Prior art and its problems] R,S-mandelic acid (racemic form), which was chemically synthesized using a known method for producing R(-)-mandelic acid, was prepared by (1) racemic resolution by fractional crystallization [ See Japanese Patent Application Laid-Open No. 58-177933], (2
) Racemic resolution by chromatography [EP 98
707], (3) racemic ester and racemic resolution by enzymatic asymmetric hydrolysis [K. Mori
et al. , Tetrahedron 36,
91 (1980)],
(4) Chemical asymmetric synthesis method using chiral reagents [D.
A. Evans et al. , J. Am. C
hem. Soc. 107, 4346 (198
5) Reference] etc. In addition to the above-mentioned ester asymmetric hydrolysis method, biological methods include (5) Microbial asymmetric reduction of benzoylformic acid [JP-A-57-198
096], (6) Hydrolysis of R(-)-mandelonitrile asymmetrically synthesized by D-oxynitrilase [see JP-A-63-219388], (
7) Failure of racemic mandelonitrile or mandelamide by microorganisms of the genus Alcaligenes, Pseudomonas, Rhodopseudomonas, Corynebacterium, Acinetobacter, Bacillus, Mycobacterium, Rhodococcus or Candida. Method for producing R(-)-mandelic acid by simultaneous hydrolysis [JP-A-2-841
98] and the like are known.
【0003】しかし、ラセミ分割による方法はいずれの
方法においてもプロセスの複雑化と各段階での収率の低
下を引き起こすこと、キラル試薬を触媒とした不斉合成
法ではキラル試薬が高価である上に高い光学純度の生成
物が得にくいという問題がある。生物学的方法であるベ
ンゾイルギ酸の不斉還元法においては基質の合成とNA
DH再成系の維持に難点が有り、またD−オキシニトリ
ラーゼ法は未だ充分な工業化研究が行なわれていない。
ラセミ体のマンデロニトリルまたはマンデルアミドから
のR(−)−マンデル酸の生産に関しては、ラセミ体の
原料から直接優位量の光学活性体を得るものではなく、
残存する他方の光学活性を有する未反応のニトリルもし
くはアミドは回収され、酸を用いた加水分解により他方
の光学活性な有機酸に変換されるか、アルカリ処理によ
りラセミ体となし、再び原料として使用され、R(−)
−マンデル酸の生産に利用されている。この方法におい
ても残存する他方の光学活性なマンデロニトリルまたは
マンデルアミドの分離とアルカリ処理によるラセミ化反
応のプロセスは複雑となり、収率の低下も引き起こされ
ることになる。このように従来の方法は種々の問題点を
含み、いずれも工業的に有利なR(−)−マンデル酸の
製造法とはなり難い。However, any method based on racemic resolution complicates the process and reduces the yield at each step, and in the asymmetric synthesis method using a chiral reagent as a catalyst, the chiral reagent is expensive and However, there is a problem in that it is difficult to obtain products with high optical purity. In the biological method of asymmetric reduction of benzoylformic acid, the synthesis of the substrate and the NA
There are difficulties in maintaining the DH regeneration system, and sufficient research on industrialization of the D-oxynitrilase method has not yet been conducted. Regarding the production of R(-)-mandelic acid from racemic mandelonitrile or mandelamide, a predominant amount of the optically active form is not directly obtained from the racemic raw material;
The remaining unreacted nitrile or amide with the other optical activity is recovered and converted to the other optically active organic acid by hydrolysis with an acid, or made into a racemic form by alkali treatment, and used again as a raw material. and R(-)
-Used in the production of mandelic acid. Even in this method, the separation of the remaining optically active mandelonitrile or mandelamide and the process of racemization reaction by alkali treatment are complicated, resulting in a decrease in yield. As described above, the conventional methods include various problems, and it is difficult for any of them to be an industrially advantageous method for producing R(-)-mandelic acid.
【0004】0004
【問題点を解決するための手段】本発明者らは、R(−
)−マンデル酸の工業的に有利な製造方法の開発を目的
に検討を進めた結果、R,S−マンデロニトリル、また
はベンズアルデヒドと青酸の混合系に、中性付近ないし
は塩基性の水性媒体中で、該ニトリルに対して加水分解
能を有する微生物を作用させることにより、定量的にR
,S−マンデロニトリル、またはベンズアルデヒドと青
酸をR(−)−マンデル酸に変換し得ることを見出し本
発明を完成した。[Means for solving the problem] The present inventors have discovered that R(-
) - As a result of conducting studies aimed at developing an industrially advantageous production method for mandelic acid, we found that R,S-mandelonitrile or a mixed system of benzaldehyde and hydrocyanic acid was added to a near-neutral or basic aqueous medium. By treating the nitrile with a microorganism capable of hydrolyzing it, R can be quantitatively reduced.
, S-mandelonitrile, or benzaldehyde and hydrocyanic acid can be converted into R(-)-mandelic acid, and the present invention was completed.
【0005】すなわち、本発明は、シュードモナス(P
seudomonas) 属、アルカリゲネス(Al−
caligenes)属、アシネトバクター(Acin
etobacter) 属またはカセオバクター(Ca
−seobacter)属に属し、R,S−マンデロニ
トリルのニトリル基を立体選択的に加水分解する能力を
有する微生物または該処理物を、中性付近ないし塩基性
の水性媒体中で、R,S−マンデロニトリルまたはベン
ズアルデヒドと青酸の混合物に作用させることにより、
原料のR,S−マンデロニトリルまたはベンズアルデヒ
ドと青酸から直接優位量のR(−)−マンデル酸を生成
せしめることを特徴とするR(−)−マンデル酸の製造
法、である。[0005] That is, the present invention is directed to Pseudomonas (P.
seudomonas), Alcaligenes (Al-
caligenes), Acinetobacter (Acin)
Etobacter genus or Caseobacter (Ca
-seobacter) and has the ability to stereoselectively hydrolyze the nitrile group of R,S-mandelonitrile, or the treated product is treated with R,S - by acting on a mixture of mandelonitrile or benzaldehyde and hydrocyanic acid,
This is a method for producing R(-)-mandelic acid, which is characterized in that a predominant amount of R(-)-mandelic acid is directly produced from raw materials R,S-mandelonitrile or benzaldehyde and hydrocyanic acid.
【0006】上記したところを要旨とする本発明は、R
,S−マンデロニトリルが、中性付近ないしは塩基性の
水性媒体中で、ベンズアルデヒドと青酸との間で解離平
衡することによりマンデロニトリルが容易にラセミ化す
るという性質を利用し、このラセミ化反応の系とマンデ
ロニトリルの不斉加水分解活性を有する微生物とを共役
させることにより、R,S−マンデロニトリルを直接R
−体優位にR(−)−マンデル酸に変換し得るとの本発
明者らにより見出された知見に基づくものである。[0006] The present invention, which has the gist of the above, is based on R
, S-mandelonitrile is easily racemized by taking advantage of the property that mandelonitrile is easily racemized by dissociative equilibrium between benzaldehyde and hydrocyanic acid in a near-neutral or basic aqueous medium. By conjugating the reaction system with a microorganism having asymmetric hydrolysis activity for mandelonitrile, R,S-mandelonitrile can be directly converted into R
This is based on the finding by the present inventors that it can be converted to R(-)-mandelic acid in a predominant manner.
【0007】本発明に用いられる微生物は、シュードモ
ナス(Pseudomonas) 属、アルカリゲネス
(Alcaligenes) 属、アシネトバクター(
Acinetobacter) 属またはカセオバクタ
ー(Caseobacter) 属に属するR(−)−
マンデル酸生産菌であり、具体的には、シュードモナス
sp. BC13−2 (微工研条寄第3319号)
、シュードモナス sp. BC15−2 (微工研条
寄第3320号)、アルカリゲネス sp. BC12
−2 (微工研菌寄第11263 号)、アルカリゲネ
ス sp. BC20 (微工研菌寄第11264 号
)、アルカリゲネスsp. BC35−2(微工研条寄
第3318号)、アルカリゲネス sp. BC24
(微工研菌寄第12063 号)、アシネトバクター
sp. BC9−2 (微工研条寄第3317号)、
カセオバクター sp. BC4(微工研条寄第331
6号)およびカセオバクター sp. BC23 (微
工研菌寄第11261 号)の菌株を挙げることができ
る。これらの微生物は、いずれも本発明者により見出さ
れ工業技術院微生物工業技術研究所(微工研)に上記番
号にて寄託されており、それぞれの菌学的性質は以下に
示すとおりである。[0007] The microorganisms used in the present invention include Pseudomonas genus, Alcaligenes genus, Acinetobacter (
R(-)- belonging to the genus Acinetobacter or the genus Caseobacter
Mandelic acid producing bacteria, specifically Pseudomonas sp. BC13-2 (Feikokenjoyori No. 3319)
, Pseudomonas sp. BC15-2 (Feikoken Article No. 3320), Alcaligenes sp. BC12
-2 (Feikoken Bacteria No. 11263), Alcaligenes sp. BC20 (Feikoken Bacteria No. 11264), Alcaligenes sp. BC35-2 (Feikoken Article No. 3318), Alcaligenes sp. BC24
(Feikoken Bacteria Serial No. 12063), Acinetobacter
sp. BC9-2 (Feikokenjoyori No. 3317),
Caseobacter sp. BC4 (Feikokenjoyori No. 331
No. 6) and Caseobacter sp. The bacterial strain BC23 (Feikoken Bacteria No. 11261) can be mentioned. All of these microorganisms were discovered by the present inventor and have been deposited with the above numbers at the Institute of Microbial Technology, Agency of Industrial Science and Technology, and their mycological properties are as shown below. .
【表1】[Table 1]
【表2】[Table 2]
【0008】以上の菌学的性質をバージェーズ マニ
ュアルオブ システマティック バクテリオロジー
(Bergey’s Manual of Syste
matic Bacteriology, 1986)
に従って分類すると、BC13−2およびBC15−2
菌株はシュードモナス(Pseudomonas) 属
、BC12−2、BC20、BC35−2およびBC2
4菌株はアルカリゲネス(Alcaligenes)
属、BC9−2 菌株はアシネトバクター(Acine
tobacter) 属、BC4 およびBC23菌株
はカセオバクター(Caseobacter) 属に属
する細菌と同定された。The above mycological properties are summarized in Bergey's Manual of Systematic Bacteriology.
matic Bacteriology, 1986)
Classified according to BC13-2 and BC15-2
The strains are Pseudomonas spp., BC12-2, BC20, BC35-2 and BC2.
4 strains are Alcaligenes
Genus, BC9-2 strain is Acinetobacter (Acinetobacter).
strains BC4 and BC23 were identified as bacteria belonging to the genus Caseobacter.
【0009】次に本発明の実施態様について説明する。
本発明に使用される微生物の培養は、資化し得る炭素源
(グリセロール、グルコース、サッカロース、カザミノ
酸、肉エキス、酵母エキス、麦芽エキス、ラクトース、
フルクトースなど)、窒素源(酵母エキスなど)、各微
生物に必須の無機塩(塩化マグネシウム、硫酸ナトリウ
ム、塩化カルシウム、硫酸マンガン、塩化鉄、硫酸亜鉛
など)等を含有した通常の培地を用いて行われる。Next, embodiments of the present invention will be explained. The microorganisms used in the present invention are cultured using assimilable carbon sources (glycerol, glucose, sucrose, casamino acids, meat extract, yeast extract, malt extract, lactose,
This is done using a normal medium containing a nitrogen source (such as yeast extract), an inorganic salt essential for each microorganism (such as magnesium chloride, sodium sulfate, calcium chloride, manganese sulfate, iron chloride, zinc sulfate, etc.), etc. be exposed.
【0010】培養初期または中期に生育を大きく阻害し
ない濃度のニトリル類(ケイ皮酸ニトリル、ベンジルシ
アニド、イソブチロニトリル、β−フェニルプロピオニ
トリル、ベンゾニトリル、2−シアノピリジン、3−シ
アノピリジン、4−シアノピリジン、フェニルスルフォ
ニルアセトニトリル、ε−カプロラクタム、γ−ブチロ
ニトリル、N(2−シアノエチル)モルホリン、アミド
類(イソブチルアミド、4−ピリジンカルボン酸アミド
、フェニルアセトアミドなど)の添加は、高い酵素活性
が得られるので好ましい。培養液のpHは4〜10の範
囲で、培養は温度20〜50℃で、1〜7日程度好気的
に行われる。Nitriles (cinnamic acid nitrile, benzyl cyanide, isobutyronitrile, β-phenylpropionitrile, benzonitrile, 2-cyanopyridine, 3-cyanopyridine) at a concentration that does not significantly inhibit growth during the early or middle stage of culture. , 4-cyanopyridine, phenylsulfonylacetonitrile, ε-caprolactam, γ-butyronitrile, N(2-cyanoethyl)morpholine, and amides (isobutyramide, 4-pyridinecarboxylic acid amide, phenylacetamide, etc.) increase enzyme activity. The pH of the culture solution is preferably in the range of 4 to 10, and the culture is carried out aerobically at a temperature of 20 to 50° C. for about 1 to 7 days.
【0011】マンデロニトリルの不斉加水分解は、上記
の様にして培養した微生物の培養液から分離した菌体ま
たは菌体処理物(増殖後の菌体の破砕物、乾燥菌体ある
いは分離精製されたマンデロニトリル不斉加水分解酵素
など)等を水または緩衝液に懸濁し、これにマンデロニ
トリルまたはベンズアルデヒドと青酸を共存させればよ
い。本発明においては、前述のようにマンデロニトリル
をラセミ化するために、反応中、系を中性付近ないしは
塩基性に保つことが必須であり、pHを4〜11、好ま
しくは6〜10に調整する。その他、本発明における反
応条件は、ベンズアルデヒドや青酸に対する酵素の感受
性により一概に特定し得ないが、通常、反応液中のマン
デロニトリルは 0.1〜2.0 重量%、好ましくは
0.5〜1.0 重量%、ベンズアルデヒドは 0.
1〜1.0 重量%、好ましくは 0.1〜0.5重量
%、青酸は 0.1〜0.5 重量%、好ましくは 0
.1〜0.2 重量%であり、マンデロニトリルに対す
る微生物の使用量は、乾燥菌体として0.01〜5.0
重量%、反応温度は0〜50℃、好ましくは10〜3
0℃で 0.1〜24時間反応させればよい。Asymmetric hydrolysis of mandelonitrile is carried out using bacterial cells isolated from the culture solution of the microorganisms cultured as described above or a treated bacterial cell product (crushed bacterial cells after multiplication, dried bacterial cells, or separated and purified microorganisms). Mandelonitrile asymmetric hydrolase, etc.) may be suspended in water or a buffer solution, and mandelonitrile or benzaldehyde and hydrocyanic acid may be allowed to coexist in this suspension. In the present invention, in order to racemize mandelonitrile as described above, it is essential to maintain the system near neutrality or basicity during the reaction, and the pH is kept at 4 to 11, preferably 6 to 10. adjust. In addition, although the reaction conditions in the present invention cannot be absolutely specified due to the sensitivity of the enzyme to benzaldehyde and hydrocyanic acid, the amount of mandelonitrile in the reaction solution is usually 0.1 to 2.0% by weight, preferably 0.5% by weight. ~1.0 wt%, benzaldehyde 0.
1 to 1.0% by weight, preferably 0.1 to 0.5% by weight, and prussic acid 0.1 to 0.5% by weight, preferably 0
.. 1 to 0.2% by weight, and the amount of microorganisms used relative to mandelonitrile is 0.01 to 5.0% as dry bacterial cells.
% by weight, reaction temperature is 0-50°C, preferably 10-3
The reaction may be carried out at 0°C for 0.1 to 24 hours.
【0012】加水分解反応で生成したR(−)−マンデ
ル酸は公知の方法、例えば遠心分離により微生物を除き
、さらに必要であれば限外ろ過などにより顆粒成分と蛋
白、多糖成分の除去を行ない、また必要であれば活性炭
処理を施した後、減圧濃縮、または酸性下での有機溶媒
による抽出を行ない、酢酸エチルエステルなどを用いて
再結晶をくり返すことにより高純度結晶を得ることがで
きる。R(-)-mandelic acid produced by the hydrolysis reaction is subjected to known methods such as centrifugation to remove microorganisms, and if necessary, ultrafiltration or the like to remove granular components, proteins, and polysaccharide components. If necessary, after treatment with activated carbon, high purity crystals can be obtained by concentrating under reduced pressure or extracting with an organic solvent under acidic conditions, and repeating recrystallization using ethyl acetate etc. .
【0013】[0013]
【発明の効果】本発明によれば、光学純度がほぼ 10
0%eeでR(−)−マンデル酸酸への選択性がほぼ定
量的であり、ラセミ体のR,S−マンデロニトリルまた
はベンズアルデヒドと青酸から光学分割することなく直
接優位量(50〜100%)のR(−)−マンデル酸が
製造でき、化学量論的に全ての原料をR(−)−マンデ
ル酸に変換することも可能であり、極めて効率のよいR
(−)−マンデル酸の製造法を提供し得る。[Effect of the invention] According to the present invention, the optical purity is approximately 10.
At 0% ee, the selectivity to R(-)-mandelic acid is almost quantitative, and the dominant amount (50 to 100 %) of R(-)-mandelic acid, and it is also possible to stoichiometrically convert all raw materials to R(-)-mandelic acid, making it an extremely efficient R(-)-mandelic acid.
A method for producing (-)-mandelic acid can be provided.
【0014】[0014]
【実施例】次に、本発明を実施例により更に詳細に説明
するが、本発明の範囲は実施例に限定されるものではな
い。EXAMPLES Next, the present invention will be explained in more detail with reference to Examples, but the scope of the present invention is not limited to the Examples.
【0015】実施例1
(1) 培養
表1に示す菌株を下記の条件で培養した。
i) 培地
グリセロール 2.0 %
(W/V)酵母エキス
0.30 %(W/V)リン酸一カリウム
0.68 %(W/V)リン酸二ナトリウム
0.71 %(W/V)硫酸ナトリウム
0.28 %(W/V)塩化マグネ
シウム 0.04 %(W/V)塩化
カルシウム 0.004 %(W/
V)硫酸マンガン 4×10−4%
(W/V)塩化鉄 6
×10−5%(W/V)硫酸亜鉛
3×10−5%(W/V)寒天
1.80 %(W/V)
ベンジルシアニド 0.02 %(W
/V)pH
7.5ii)培養条件
上記平板培地にて30℃、72時間培養した。Example 1 (1) Culture The strains shown in Table 1 were cultured under the following conditions. i) Medium glycerol 2.0%
(W/V) Yeast extract
0.30% (W/V) monopotassium phosphate
0.68% (W/V) Disodium Phosphate
0.71% (W/V) Sodium Sulfate
0.28% (W/V) Magnesium chloride 0.04% (W/V) Calcium chloride 0.004% (W/V)
V) Manganese sulfate 4x10-4%
(W/V) Iron chloride 6
×10-5% (W/V) zinc sulfate
3 x 10-5% (W/V) agar
1.80% (W/V)
Benzyl cyanide 0.02% (W
/V) pH
7.5ii) Culture conditions Culture was carried out at 30° C. for 72 hours in the above plate medium.
【0016】(2) マンデロニトリルの不斉加水分解
平板培地から菌体を採集し50mMリン酸緩衝液(pH
7.5)で洗浄し、同リン酸緩衝液10mlに懸濁し
、OD630 =1〜50となる様な菌体濃度の休止菌
体反応液を調整した。この液にマンデロニトリルを 0
.2%(W/V)となる様に添加し、30℃で16〜2
4時間反応を行った。反応終了液を液体クロマトグラフ
ィー(Shiseido ODScolumn) によ
り分析を行ったところ、マンデル酸とアンモニアが生成
していた。また、光学分割用キラルセル(CHIRAL
PAK WH column)により光学純度を分析し
たところ、高い光学純度のR(−)−マンデル酸を生成
していた。結果を表1に示す。(2) Asymmetric hydrolysis of mandelonitrile Bacterial cells were collected from the plate culture medium and diluted with 50mM phosphate buffer (pH
7.5) and suspended in 10 ml of the same phosphate buffer to prepare a resting cell reaction solution with a cell concentration such that OD630 = 1 to 50. Add mandelonitrile to this liquid
.. 2% (W/V) and 16-2% at 30°C.
The reaction was carried out for 4 hours. When the reaction completed liquid was analyzed by liquid chromatography (Shiseido ODS column), it was found that mandelic acid and ammonia were produced. In addition, a chiral cell for optical resolution (CHIRAL)
When the optical purity was analyzed using PAK WH column), it was found that R(-)-mandelic acid with high optical purity was produced. The results are shown in Table 1.
【表3】[Table 3]
【0017】実施例2
(1) 培養
アルカリげネス sp. BC12−2 株を下記の条
件で養した。
i) 培地
(A培地)
グリセロール 2.0 %
(W/V)酵母エキス
0.30 %(W/V)リン酸一カリウム
0.68 %(W/V)リン酸二ナトリウム
0.71 %(W/V)硫酸ナトリウム
0.28 %(W/V)塩化マグネ
シウム 0.04 %(W/V)塩化
カルシウム 0.004 %(W/
V)硫酸マンガン 4×10−4%
(W/V)塩化鉄 6
×10−5%(W/V)硫酸亜鉛
3×10−5%(W/V)pH
7.5 (B培地)
A培地に0.02%(W/V)のベンジルシアニドを添
加したものをB培地とする
ii)培養条件
A培地にて30℃、72時間培養後、得られた菌体を更
にB培地にて30℃、48時間培養した。Example 2 (1) Cultured Alkalinenes sp. The BC12-2 strain was cultivated under the following conditions. i) Medium (A medium) Glycerol 2.0%
(W/V) Yeast extract
0.30% (W/V) monopotassium phosphate
0.68% (W/V) Disodium Phosphate
0.71% (W/V) Sodium Sulfate
0.28% (W/V) Magnesium chloride 0.04% (W/V) Calcium chloride 0.004% (W/V)
V) Manganese sulfate 4x10-4%
(W/V) Iron chloride 6
×10-5% (W/V) zinc sulfate
3 x 10-5% (W/V) pH
7.5 (Medium B) Medium B is made by adding 0.02% (W/V) benzyl cyanide to medium A. ii) Culture conditions After culturing in medium A at 30°C for 72 hours, the obtained The cells were further cultured in medium B at 30°C for 48 hours.
【0018】(2) マンデロニトリルの不斉加水分解
得られた培養液から菌体を分離して50mMリン酸緩衝
液(pH 7.5)で洗浄し、同リン酸緩衝液100m
l に懸濁し、休止菌体反応液を調整した(OD630
=50.48)。この液にマンデロニトリルを 0.
2g添加し、30℃で反応を行った。
反応開始後1時間でマンデロニトリルが完全に消失し、
R(−)−マンデル酸とアンモニアがほぼ定量的に生成
していた。さらにマンデロニトリルを 0.2gを1時
間毎に逐次添加しながら反応を続け都合14時間反応を
行った。液体クロマトグラフィー(Shisei−do
ODS column)により分析を行ったところ、
反応開始後14時間で2.73%(W/V)(転換収率
; 88.93%)のR(−)−マンデル酸アンモニウ
ムが蓄積した。反応終了液は遠心除菌後、酸処理により
pH 2とし酢酸エチルエステルにてマンデル酸を抽出
した。得られたマンデル酸溶液は無水硫酸ナトリウムで
乾燥した後、有機溶媒を溜去することにより粗結晶を得
た。得られた結晶は酢酸エチルエステルにより再結晶を
行い白色粉末結晶を得た。尚、得られた結晶と標準のマ
ンデル酸は6Nアンモニア水に溶解後、 1.0%(W
/V)の濃度となる様に蒸留水でメスアップしてマンデ
ル酸アンモニウムとなし、表2にその分析結果を示す。(2) Asymmetric hydrolysis of mandelonitrile Bacterial cells were separated from the resulting culture solution, washed with 50mM phosphate buffer (pH 7.5), and washed with 100mM of the same phosphate buffer.
1 to prepare a resting bacterial cell reaction solution (OD630
=50.48). Add 0.00 mandelonitrile to this solution.
2g was added and the reaction was carried out at 30°C. One hour after the start of the reaction, mandelonitrile completely disappeared,
R(-)-mandelic acid and ammonia were produced almost quantitatively. Further, 0.2 g of mandelonitrile was successively added every hour while the reaction continued for a total of 14 hours. Liquid chromatography (Shisei-do)
When analyzed using ODS column),
2.73% (W/V) (conversion yield; 88.93%) of R(-)-ammonium mandelate was accumulated 14 hours after the start of the reaction. After the reaction completed, the solution was sterilized by centrifugation, the pH was adjusted to 2 by acid treatment, and mandelic acid was extracted with ethyl acetate. The obtained mandelic acid solution was dried over anhydrous sodium sulfate, and then the organic solvent was distilled off to obtain crude crystals. The obtained crystals were recrystallized with ethyl acetate to obtain white powder crystals. The obtained crystals and standard mandelic acid were dissolved in 6N aqueous ammonia, and then dissolved at 1.0% (W
/V) was diluted with distilled water to obtain ammonium mandelate, and Table 2 shows the analysis results.
【表4】[Table 4]
【0019】実施例3
(1) 培養
アルカリゲネス sp. BC35−2 株を実施例2
と同様の培養条件で培養した。
(2) マンデロニトリルの不斉加水分解得られた培養
液から実施例1と同様の方法で菌体を取得し、菌体濃度
OD630 =59.50 にて実施例1と同一の反応
条件で反応を開始し、蓄積試験を行った。反応開始後1
4時間までは、基質は完全に消失し、反応開始後、42
時間で反応液中のマンデル酸アンモニウム含量は3.7
9%(W/V)(転換収率;89.09 %)まで蓄積
した。以下、実施例2と同様の操作を行い、表3に示す
結果を得た。Example 3 (1) Cultured Alcaligenes sp. Example 2 of BC35-2 strain
The cells were cultured under the same culture conditions. (2) Bacterial cells were obtained from the culture solution obtained by asymmetric hydrolysis of mandelonitrile in the same manner as in Example 1, and under the same reaction conditions as in Example 1 at a cell concentration of OD630 = 59.50. The reaction was started and an accumulation test was performed. After starting the reaction 1
By 4 hours, the substrate had completely disappeared, and after the start of the reaction, 42
The ammonium mandelate content in the reaction solution was 3.7 hours.
It was accumulated to 9% (W/V) (conversion yield; 89.09%). Thereafter, the same operations as in Example 2 were performed, and the results shown in Table 3 were obtained.
【表5】[Table 5]
【0020】実施例4
(1) 培養
シュ−ドモナス sp. BC12−2 株を実施例2
と同様の培養条件で培養した。
(2) ベンズアルデヒドと青酸からのR(−)−マン
デル酸の生産
得られた培養液から、実施例1と同様の方法で菌体を取
得し、50mMリン酸緩衝液(pH 7.5)100m
l に懸濁し、休止菌体反応液を調整した(OD630
=50.5) 。この液にベンズアルデヒドと青酸を
各々について終濃度15mMとなる様な濃度に添加し、
30℃で反応を開始した。反応開始後1時間で解離平衡
により生成したマンデロニトリルおよびベンズアルデヒ
ドが完全に消失しR(−)−マンデル酸とアンモニアが
定量的に生成していた。さらにベンズアルデヒドと青酸
各15mMを1時間毎に逐次添加したところ反応開始後
14時間で 2.6%(W/V)のR(−)−マンデル
酸アンモニウムが蓄積した(転換収率;84.7%)。
また、実施例2と同様の操作を行ったところ、光学純度
は 100%eeであった。Example 4 (1) Cultured Pseudomonas sp. Example 2 using BC12-2 strain
The cells were cultured under the same culture conditions. (2) Production of R(-)-mandelic acid from benzaldehyde and hydrocyanic acid From the obtained culture solution, bacterial cells were obtained in the same manner as in Example 1, and 100 m
1 to prepare a resting bacterial cell reaction solution (OD630
=50.5). Benzaldehyde and hydrocyanic acid were added to this solution to a final concentration of 15 mM each,
The reaction was started at 30°C. One hour after the start of the reaction, mandelonitrile and benzaldehyde produced by dissociation equilibrium completely disappeared, and R(-)-mandelic acid and ammonia were quantitatively produced. Further, when 15 mM each of benzaldehyde and hydrocyanic acid were added sequentially every hour, 2.6% (W/V) of R(-)-ammonium mandelate was accumulated 14 hours after the start of the reaction (conversion yield: 84.7 %). Further, when the same operation as in Example 2 was performed, the optical purity was 100%ee.
Claims (1)
カリゲネス(Alcaligenes) 属、アシネト
バクター(Acinetobacter) 属またはカ
セオバクター(Caseobacter) 属に属し、
R,S−マンデロニトリルのニトリル基を立体選択的に
加水分解する能力を有する微生物または該処理物を、中
性付近ないし塩基性の水性媒体中で、R,S−マンデロ
ニトリルまたはベンズアルデヒドと青酸の混合物に作用
させることにより、原料のR,S−マンデロニトリルま
たはベンズアルデヒドと青酸から直接優位量のR(−)
−マンデル酸を生成せしめることを特徴とするR(−)
−マンデル酸の製造法。Belonging to the genus Pseudomonas, genus Alcaligenes, genus Acinetobacter or genus Caseobacter,
Microorganisms having the ability to stereoselectively hydrolyze the nitrile group of R,S-mandelonitrile or the treated product are mixed with R,S-mandelonitrile or benzaldehyde in a near neutral to basic aqueous medium. By acting on a mixture of hydrocyanic acid, a predominant amount of R(-) can be obtained directly from the raw material R,S-mandelonitrile or benzaldehyde and hydrocyanic acid.
-R(-) characterized by producing mandelic acid
- A method for producing mandelic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8918991A JP2696436B2 (en) | 1990-03-30 | 1991-03-29 | Method for producing R (-)-mandelic acid |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8069490 | 1990-03-30 | ||
JP2-80694 | 1990-03-30 | ||
JP8918991A JP2696436B2 (en) | 1990-03-30 | 1991-03-29 | Method for producing R (-)-mandelic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04218385A true JPH04218385A (en) | 1992-08-07 |
JP2696436B2 JP2696436B2 (en) | 1998-01-14 |
Family
ID=26421668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8918991A Expired - Lifetime JP2696436B2 (en) | 1990-03-30 | 1991-03-29 | Method for producing R (-)-mandelic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2696436B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03277292A (en) * | 1990-03-22 | 1991-12-09 | Asahi Chem Ind Co Ltd | Production of optically active 2-hydroxycarboxylic acid |
EP0773297A2 (en) | 1995-11-10 | 1997-05-14 | Nitto Chemical Industry Co., Ltd. | Process for producing alfa-hydroxy acid or alfa-hydroxyamide by microorganism |
US6582943B1 (en) | 2002-02-05 | 2003-06-24 | E. I. Du Pont De Nemours And Company | Method for producing 2-hydroxyisobutyric acid and methacrylic acid from acetone cyanohydrin |
US7871802B2 (en) | 2007-10-31 | 2011-01-18 | E.I. Du Pont De Nemours And Company | Process for enzymatically converting glycolonitrile to glycolic acid |
CN114410699A (en) * | 2021-12-27 | 2022-04-29 | 安徽泰格生物科技有限公司 | Method for producing R-mandelic acid by biological catalysis |
-
1991
- 1991-03-29 JP JP8918991A patent/JP2696436B2/en not_active Expired - Lifetime
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03277292A (en) * | 1990-03-22 | 1991-12-09 | Asahi Chem Ind Co Ltd | Production of optically active 2-hydroxycarboxylic acid |
JP2696127B2 (en) * | 1990-03-22 | 1998-01-14 | 旭化成工業株式会社 | Method for producing optically active 2-hydroxycarboxylic acid |
EP0773297A2 (en) | 1995-11-10 | 1997-05-14 | Nitto Chemical Industry Co., Ltd. | Process for producing alfa-hydroxy acid or alfa-hydroxyamide by microorganism |
US6582943B1 (en) | 2002-02-05 | 2003-06-24 | E. I. Du Pont De Nemours And Company | Method for producing 2-hydroxyisobutyric acid and methacrylic acid from acetone cyanohydrin |
US7871802B2 (en) | 2007-10-31 | 2011-01-18 | E.I. Du Pont De Nemours And Company | Process for enzymatically converting glycolonitrile to glycolic acid |
CN114410699A (en) * | 2021-12-27 | 2022-04-29 | 安徽泰格生物科技有限公司 | Method for producing R-mandelic acid by biological catalysis |
Also Published As
Publication number | Publication date |
---|---|
JP2696436B2 (en) | 1998-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0449648B1 (en) | Process for producing R(-)-mandelic acid and derivatives thereof | |
JP2676568B2 (en) | Method for producing R (-)-mandelic acid and its derivatives | |
JP3218133B2 (en) | Method for producing optically active α-hydroxycarboxylic acid having phenyl group | |
US5580765A (en) | Process for producing optically active a-hydroxycarboxylic acid having phenyl group using gordona terrae | |
JP2950896B2 (en) | Method for producing D-α-phenylglycine | |
JP2696424B2 (en) | Method for producing R (-)-mandelic acid | |
JP3154646B2 (en) | Microbial production of glycolic acid | |
JPH04218385A (en) | Production of r(-)-mandelic acid | |
JP3081649B2 (en) | Process for producing S-(+)-mandelamide and its derivatives | |
JP3146640B2 (en) | Method for producing benzoylformic acid | |
JP2924679B2 (en) | Production method of D-lysine | |
JP3090761B2 (en) | Production method of optically active lactic acid | |
JP3817725B2 (en) | Method for producing pyruvic acid | |
JPH05176794A (en) | Production of optically active 2-phenylpropionic acid and 2-phenylpropionamide | |
JPH05284982A (en) | Production of racemic 2-aminonitrile by microorganism | |
JPH11243979A (en) | Production of pyruvic acid | |
JPH07115989A (en) | Production of optically active alpha-hydroxycarboxylic acid and alpha-hydroxyamide | |
JPH08154692A (en) | Production of d-2-aminobutyric acid | |
JPH0378999B2 (en) | ||
JPH0975097A (en) | Production of d-amino acid | |
JPH0556953B2 (en) | ||
JPH05219969A (en) | Biological production of alpha-hydroxylisobutyric acid | |
JPH06237776A (en) | Production of alpha-hydroxyisobutyric acid | |
JPH07274985A (en) | Production of d-gamma-methylleucine | |
JPH02119785A (en) | Production of 2-oxo-4-phenylbutyric acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070919 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080919 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080919 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090919 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100919 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110919 Year of fee payment: 14 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110919 Year of fee payment: 14 |